Skip to main content
    I

    Intuitive Surgical Inc (ISRG)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $451.63
    -0.66 (-0.15%)

    Market Cap: $159.78B

    Last updated: Oct 27, 2026 at 10:41 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(36/40)
    Avg Surprise
    +14.40%
    Streak
    15 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$4.01
    Range$3.89 - $4.10
    23 analysts
    Revenue Consensus
    $3.6B
    Range$3.2B - $3.7B
    26 analysts
    Period ending Mar 31, 2027
    EPS Consensus$2.84
    Range$2.62 - $3.01
    22 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$2.77+2.6%
    60d ago$2.80+1.7%
    30d ago$2.80+1.8%
    7d ago$2.80+1.7%
    Current$2.84
    Revenue Consensus
    $3.1B
    Range$3.0B - $3.2B
    19 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    		-$2.84---
    Dec 26EST
    		-$4.01---
    Sep 26
    Reported Oct 20
    		$2.53$2.13+18.78%Beat+5.4%
    Jun 26
    Reported Jul 16
    		$2.80$2.02+38.61%Beat+27.9%
    Mar 26
    Reported Apr 21
    		$2.50$2.11+18.48%Beat+38.1%
    Dec 25
    Reported Jan 22
    		$2.53$2.27+11.45%Beat+14.5%
    Sep 25
    Reported Oct 21
    		$2.40$1.99+20.60%Beat+30.4%
    Jun 25
    Reported Jul 22
    		$2.19$1.92+14.06%Beat+23.0%
    Mar 25
    Reported Apr 22
    		$1.81$1.73+4.62%Beat+20.7%
    Dec 24
    Reported Jan 23
    		$2.21$1.79+23.46%Beat+38.1%
    Sep 24
    Reported Oct 17
    		$1.84$1.64+12.20%Beat+26.0%
    Jun 24
    Reported Jul 18
    		$1.78$1.54+15.58%Beat+25.4%
    Mar 24
    Reported Apr 18
    		$1.50$1.42+5.63%Beat+22.0%
    Dec 23
    Reported Jan 23
    		$1.60$1.49+7.38%Beat+30.1%
    Sep 23
    Reported Oct 19
    		$1.46$1.42+2.82%Beat+22.7%
    Jun 23
    Reported Jul 20
    		$1.42$1.33+6.77%Beat+24.6%
    Mar 23
    Reported Apr 18
    		$1.23$1.20+2.50%Beat+8.8%
    Dec 22
    Reported Jan 24
    		$1.23$1.25-1.60%Miss-5.4%
    Sep 22
    Reported Oct 18
    		$1.19$1.12+6.25%Beat+0.0%
    Jun 22
    Reported Jul 21
    		$1.14$1.20-5.00%Miss-13.0%
    Mar 22
    Reported Apr 21
    		$1.13$1.08+4.63%Beat-3.4%
    Dec 21
    Reported Jan 20
    		$1.30$1.28+1.56%Beat+9.2%
    Sep 21
    Reported Oct 19
    		$1.19$1.16+2.59%Beat+29.3%
    Jun 21
    Reported Jul 20
    		$1.31$1.02+28.43%Beat+254.1%
    Mar 21
    Reported Apr 20
    		$1.17$0.88+32.95%Beat+30.0%
    Dec 20
    Reported Jan 21
    		$1.19$1.04+14.42%Beat+2.6%
    Sep 20
    Reported Oct 15
    		$0.92$0.68+35.29%Beat-19.3%
    Jun 20
    Reported Jul 21
    		$0.37$0.16+131.25%Beat-65.7%
    Mar 20
    Reported Apr 16
    		$0.90$0.85+5.88%Beat+3.4%
    Dec 19
    Reported Jan 23
    		$1.16$1.13+2.65%Beat+17.2%
    Sep 19
    Reported Oct 17
    		$1.14$1.00+14.00%Beat+21.3%
    Jun 19
    Reported Jul 18
    		$1.08$0.96+12.50%Beat+17.4%
    Mar 19
    Reported Apr 18
    		$0.87$0.90-3.33%Miss+7.4%
    Dec 18
    Reported Jan 24
    		$0.99$1.02-2.94%Miss+16.5%
    Sep 18
    Reported Oct 18
    		$0.94$0.89+5.62%Beat+2.2%
    Jun 18
    Reported Jul 19
    		$0.92$0.83+10.84%Beat+39.4%
    Mar 18
    Reported Apr 17
    		$0.81$0.69+17.39%Beat+42.1%
    Dec 17
    Reported Jan 25
    		$0.85$0.76+11.84%Beat+25.0%
    Sep 17
    Reported Oct 19
    		$0.92$0.66+39.39%Beat-
    Jun 17
    Reported Jul 20
    		$0.66$0.64+3.13%Beat-
    Mar 17
    Reported Apr 18
    		$0.57$0.55+3.64%Beat-
    Dec 16
    Reported Jan 24
    		$0.68$0.67+1.49%Beat-

    Key Metrics

    Valuation
    P/E Ratio43.59EV/EBITDA35.20x
    Price/FCF43.81xFCF Yield2.28%
    Profitability
    Profit Margin25.50%Operating Margin33.30%
    ROE17.90%ROIC17.82%
    Financial Health
    Debt/Equity0.04xInterest CoverageN/A
    Current Ratio3.33xQuick Ratio2.49x
    Trading Statistics
    Beta1.46Avg Volume2.30M
    52-Week High$603.8852-Week Low$328.57

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$434.39
    SMA 20$422.44
    SMA 50$397.20
    SMA 200$435.54
    EMA 10$436.39
    EMA 20$424.97
    EMA 50$407.99
    EMA 200$429.71

    MACD

    Line: 14.08Signal: 11.96Hist: 2.12

    ADX

    ADX: 15.9+DI: 28.7-DI: 22.4

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down40.0
    PSAR$402.24

    Bollinger Bands

    Upper Band$455.16
    Lower Band$389.71
    %B Position1549%(Upper)
    Band Width0.95

    RSI (14-Day)

    Overbought
    70.3

    Momentum Oscillators

    Stoch %K92.4
    Stoch %D90.3
    Williams %R-12.0
    ROC (10d)5.6%
    Momentum23.99
    CCI (20d)169.9
    MFI (14d)76.8

    Volatility Measures

    ATR (14d)$13.08(2.9%)
    StdDev (20d)16.36
    Hist Vol28.5%(Moderate)

    Volume Flow

    VWAP$452.70
    OBV20.2M
    AD Line-12.1M
    CMF (20d)0.242

    Volume Metrics

    Avg Vol (20d)2.3M
    Vol Ratio1.3x
    VWMA (20d)$425.69

    Pivot Points

    R3$475.53
    R2$466.99
    R1$459.64
    Pivot Point$451.10
    S1$443.75
    S2$435.21
    S3$427.86

    Advanced Oscillators

    TSI33.61
    Ultimate Osc67.0
    KST116.51

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$3.05B$2.89B$2.77B$2.87B$2.51B$2.44B$2.25B$2.41B$2.04B$2.01B$1.89B$1.93B
    Cost of Revenue$964.40M$931.90M$940.30M$961.90M$842.70M$822.10M$795.70M$771.30M$664.20M$637.20M$645.20M$650.90M
    Gross Profit$2.08B$1.96B$1.83B$1.90B$1.66B$1.62B$1.46B$1.64B$1.37B$1.37B$1.25B$1.28B
    Operating Expenses$1.49B$988.50M$975.20M$1.04B$902.70M$874.50M$879.60M$907.30M$796.60M$805.40M$776.00M$827.20M
    R&D$408.30M$370.60M$361.90M$352.90M$329.40M$313.30M$316.20M$294.70M$286.00M$280.10M$284.50M$260.10M
    SG&A$633.40M$617.90M$613.30M$687.10M$573.30M$561.20M$563.40M$612.60M$510.60M$525.30M$491.50M$567.10M
    Operating Income$592.60M$971.90M$855.30M$864.30M$759.70M$743.40M$578.10M$734.90M$577.30M$567.30M$469.40M$450.20M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$668.40M$1.05B$940.40M$955.60M$855.20M$832.10M$668.50M$809.80M$671.00M$654.50M$538.50M$515.90M
    Income Tax Expense$144.00M$231.40M$114.40M$156.10M$146.00M$167.90M$-35,200,000$121.80M$100.40M$123.00M$-8,900,000$-94,800,000
    Net Income$524.40M$823.20M$826.00M$799.50M$709.20M$664.20M$703.70M$688.00M$570.60M$531.50M$547.40M$610.70M
    EBITDA$872.20M$1.28B$1.13B$1.13B$1.01B$986.80M$800.40M$940.10M$784.30M$755.40M$650.40M$642.10M
    EBIT$668.40M$1.05B$940.40M$955.60M$855.20M$832.10M$668.50M$809.80M$671.00M$654.50M$538.50M$515.90M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    Globus Medical Grew Earnings 56% On 6% Revenue. The Robotics Line Went Backwards.

    Q2 non-GAAP EPS $1.34, up 55.8% y/y; revenue $789.6M, +5.9%; company kept revenue guide $3.18-3.22B and raised adjusted EPS to $4.95-5.05 from $4.70-4.80 Enabling Technologies revenue fell 25.8% to $26.1M, now 3.3% of sales - robotics is a marginal, shrinking contributor...

    Glenn Ford
    •
    8/11/26
    •
    209
    Medical Devices, value investing
    Also mentions:
    MDTISRG

    The Biggest Healthcare Disconnect In Decades - And The Stocks I’m Watching

    Healthcare has hit a 26-year relative low, but weakness alone does not make the sector a buy. AI-led capital flows, patent cliffs, IRA pricing pressure, and GLP-1 disruption explain much of the selloff. I prefer selective exposure: picks-and-shovels, AI-driven platforms...

    Leo Nelissen
    •
    5/25/26
    •
    466
    Healthcare Stocks, Dividend Investing, value investing
    Also mentions:
    TMOWSTLLYISRGPFE

    The Aristocrat Nobody Wanted: Why (MDT) Is Worth a Second Look Right Now

    (MDT) has raised its dividend for 48 consecutive years, yet trades at just 14x forward earnings. On a trailing basis it is 24x vs. (ISRG) at 57x and (SYK) at 40x. The 5-year dividend CAGR is 4.4%, slowing to 2.0% over three years. This is a yield anchor at 3.3%...

    Glenn Ford
    •
    4/8/26
    •
    165
    dividend aristocrats, value investing, Medical Devices
    Also mentions:
    ISRGABTSYK

    Why TransMedics Stock is a Buy for Long-Term Investors

    TransMedics is replacing a 60-year-old organ-transport method with its FDA-approved OCS platform, which keeps hearts, lungs, and livers alive and functioning during transit — a massive step-change in reliability and outc Business model now prints cash...

    Glenn Ford
    •
    11/14/25
    •
    295
    medical-technology, healthcare-innovation, organ-transplant, growth-stocks
    Also mentions:
    ISRGSYKMDTABTEW

    Government Contracts

    Gov Obligations (TTM)
    -$191854
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    -100.5%
    Active Awards
    17
    New Awards (TTM)
    1
    Avg Remaining Term
    4.0 mo

    Top agency: Department of Defense at 78.9% of trailing twelve month obligations across 2 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75N98026P00872Department of Health and Human ServicesNational Institutes of Health$100040Jun 26, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Intuitive Surgical VP corporate controller Fredrik Widman sells $1.83M in shares

    Fredrik Widman, VP Corporate Controller at Intuitive Surgical Inc., sold over $1.83 million worth of shares on October 23, 2026, after exercising non-qualified stock options. Following these transactions...

    Investing.com•10/27/26•Neutral

    Craig H. Barratt, director, Intuitive Surgical, sells $510,370 in stock

    Craig H. Barratt, a director at Intuitive Surgical Inc. (NASDAQ:ISRG), sold 1,150 shares of common stock for $510,370 on October 23, 2026...

    Investing.com•10/27/26•Neutral

    After selling 20,095 shares, Intuitive Surgical (ISRG) director Gary S. Guthart's trust holds 1,204,530.

    Intuitive Surgical (ISRG) director Gary S. Guthart's trust sold 20,095 shares on October 23, 2026, at a weighted average price of $451.6117 per share. This transaction was conducted under a Rule 10b5-1 Trading Plan...

    Stock Titan•10/26/26•Bearish

    Dale Brady Joins Nuwellis as Principal R&D Engineer

    Nuwellis Inc. has appointed Dale Brady as Principal R&D Engineer to advance its existing and new product development programs. Brady brings over 25 years of medical device leadership experience...

    Medical Product Outsourcing•10/26/26•Somewhat-Bullish

    Stryker Corp. Research & Ratings | SYK

    This article provides an overview of Stryker Corp. (SYK) research and ratings, including analyst consensus, price targets, and yearly/quarterly earnings estimates. It details the company's stock performance...

    Barron's•10/26/26•Neutral

    ISRG Valuation and Fair Value

    P/E
    43.6x
    Forward P/E
    33.3x
    EV/EBITDA
    35.2x
    P/FCF
    43.8x
    PEG
    1.9x
    P/B
    9.9x
    See GNG's fair value

    ISRG Profitability: Margins, ROIC and FCF

    Gross margin
    67.2%
    Operating margin
    33.3%
    Net margin
    25.5%
    ROIC
    17.8%
    ROE
    17.9%
    FCF margin
    31.1%
    FCF yield
    2.3%

    ISRG Competitors

    CompanyTicker
    Danaher CorporationDHR
    Vertex Pharmaceuticals IncVRTX
    Pfizer IncPFE
    Bristol-Myers Squibb CompanyBMY
    Novo Nordisk A/SNVO
    Medtronic PLCMDT
    Abbott LaboratoriesABT
    CVS Health CorpCVS

    Sector: Healthcare

    ISRG Analyst Ratings

    Consensus
    Buy
    Analysts
    32
    Strong Buy
    7
    Buy
    17
    Hold
    7
    Sell
    1
    Strong Sell
    0

    ISRG Bull Case vs Bear Case

    Bull case

    • ISRG earns a 17.8% return on invested capital.
    • ISRG converts 31.1% of revenue into free cash flow.
    • ISRG has a 25.5% net profit margin.

    Bear case

    • ISRG trades at 43.6x trailing earnings.

    ISRG Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    18.8%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $4.01

    Frequently Asked Questions About ISRG

    Does ISRG pay dividends?

    Intuitive Surgical Inc (ISRG) does not currently pay a regular dividend.

    What is ISRG's P/E ratio?

    Intuitive Surgical Inc has a price-to-earnings (P/E) ratio of 43.59.

    What is ISRG's market cap?

    Intuitive Surgical Inc (ISRG) has a market capitalization of $159.78B with a current stock price of $451.63.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In